PMC7607990_01
Antigram showing antibody screen positive with 3 cell panel
AJTS-14-83-g001.jpg
PMC7607990_01_AJTS-14-83-g001.jpg
F1
The antibody screen showed positive reaction with cells 2 and 3 [Figures 1 and 2].
Showing antibody screen positive with 3 cell panel
AJTS-14-83-g002.jpg
PMC7607990_01_AJTS-14-83-g002.jpg
F2
The antibody screen showed positive reaction with cells 2 and 3 [Figures 1 and 2].
Showing antibody identification using 11 cell panel
AJTS-14-83-g003.jpg
PMC7607990_01_AJTS-14-83-g003.jpg
F3
Antibody identification: eleven-cell identification panel resolve panel A (Ortho Clinical Diagnostics, Johnson and Johnson, USA) showed positive reactions with cells 1, 2, 3, 6, 8, and 10 which was suggestive of antibody against E, K, Fya, S antigens [Figures 3 and 4].
Antigram showing antibody identification using 11 cell panel
AJTS-14-83-g004.jpg
PMC7607990_01_AJTS-14-83-g004.jpg
F4
Antibody identification: eleven-cell identification panel resolve panel A (Ortho Clinical Diagnostics, Johnson and Johnson, USA) showed positive reactions with cells 1, 2, 3, 6, 8, and 10 which was suggestive of antibody against E, K, Fya, S antigens [Figures 3 and 4].
Showing use of select cell for antibody identification
AJTS-14-83-g005.jpg
PMC7607990_01_AJTS-14-83-g005.jpg
F5
A (Ortho Clinical Diagnostics, Johnson and Johnson, USA) were used, confirming the presence of Anti-Fya and anti-E alloantibody and ruled out the presence of antibody against K and S antigens [Figure 5]. Antibody titer was found to be Anti-E: 1:64 and Anti-Fya: 1:256.
Showing Rh/K phenotyping of the patient
AJTS-14-83-g006.jpg
PMC7607990_01_AJTS-14-83-g006.jpg
F6
Showing Rh/K phenotyping of patient's husband
AJTS-14-83-g007.jpg
PMC7607990_01_AJTS-14-83-g007.jpg
F7